The COVID-19 Pandemic and its Consequences for Public Health: Medico-Geographical Aspect
https://doi.org/10.24057/2071-9388-2025-3857
Abstract
The paper consists of a review of the public health consequences of the COVID-19 pandemic. The study focuses on the assessment of the impact of the COVID-19 pandemic on the incidence of the leading disease categories, such as Diseases of the Circulatory System (DCS), Malignant Neoplasms (MN) and External Causes of Morbidity and Mortality (EC) in the Russian Federation. Time series of standardized incidence for each category were examined for the period 2007–2019 (preCOVID-19), and 2020–2023 (COVID-19 and post-COVID-19). The post-COVID trends were compared to those hypothetically expected with no COVID impact. For the majority of the RF regions, upward trends of DCS and MN incidence were detected both in pre-COVID and post-COVID years. In the first year of the pandemic, a decline in morbidity was observed for all categories. The EC incidence trend was decreasing in pre-COVID years, but it increased in the post-COVID period. The median incidence rates of MN in the post-COVID period were lower than expected in most of the country, while those of DCS demonstrated heterogeneous distribution with no clear spatial patterns. A decline in the incidence of all nosoforms in 2020 may not have been related to the actual decrease of morbidity, but rather to the significant reduction of healthcare and diagnostics accessibility, which led to a reduction in the detection of diseases new cases.
Keywords
COVID-19,
Russian Federation,
ICD disease categories,
time series,
incidence trends,
trend change point,
public health consequences
Supporting agencies: The study was carried out with the support of Lomonosov Moscow State University research project No. 121051100137-4 and supported by MSU Development Program of the Interdisciplinary Scientific and Educational School «Future Planet and Global Environmental Change» and MSU Program of Development (P. 1220).
About the Authors
Svetlana M. Malkhazova
Faculty of Geography, Shenzhen MSU-BIT University ; 2Faculty of Geography, Lomonosov Moscow State University
Russian Federation
Russian Federation
Shenzhen, 517182, China
Moscow, 119991
Fedor I. Korennoy
Federal Center for Animal Health (FGBI ARRIAH)
Russian Federation
Russian Federation
Vladimir, 600901
Tamara V. Vatlina
Faculty of Natural Sciences and Geography, Smolensk State University
Russian Federation
Russian Federation
Smolensk, 214000
Li Wang
Institute of Geographic Sciences and Natural Resources Research
China
China
CAS, Beijing, 100101
Dmitry S. Orlov
Faculty of Geography, Lomonosov Moscow State University
Russian Federation
Russian Federation
Moscow, 119991
References
1. Al-Aly Z., Xie Y. and Bowe B. (2021). High-dimensional characterization of post-acute sequelae of COVID-19. Nature, 594(7862), 259–264, DOI: 10.1038/s41586-021-03553-9.
2. Alnefeesi Y., Siegel A., Lui L.M.W, Teopiz K.M., Ho R.C.M., Lee Y., Nasri F., Gill H., Lin K., Cao B., Rosenblat J.D. and McIntyre R.S. (2020). Impact of SARS-CoV-2 Infection on Cognitive Functions: A Systematic Review. Frontiers in Psychiatry, 11, 1629, DOI: 10.13140/RG.2.2.14530.40649.
3. Alov I.N. and Pilyasov A.N. (2023). The spread of the COVID-19 infection in Russia. Baltic macroregion: internal differences, Balt. Reg., Vol. 15, No. 1, 96–119, (in Russian), DOI: 10.5922/2079-8555-2023-1-6.
4. Bai Y., Yao L., Wei T., Tian F., Jin D.Y. and Chen L. (2020). Presumed asymptomatic carrier transmission of COVID-19. JAMA, DOI: 10.1001/jama.2020.2565.
5. Baklanov A.A., Chubarova N.E., Kolosov V.A., Malkhazova S.M. and Porfiriev B.N. (2021). Introduction to Geography of Covid-19 Pandemic: Environmental Issues, Public Health and Socio-Economic Consequences. Geography, Environment, Sustainability, 14(4), 105–108, DOI: 10.24057/2071-9388-2021-044.
6. Bedford J., Enria D., Giesecke J., Heymann D.L., Ihekweazu C., Kobinger G., Ungchusak K. and Wieler L.H. (2020). Living with the COVID-19 pandemic: act now with the tools we have. The Lancet, 396(10259), 1314–1316, DOI: 10.1016/S0140-6736(20)32117-6.
7. Belopasov V.V., Yashu Ya., Samoilova E.M. and Baklaushev V.P. (2020). Damage to the nervous system in COVID-19. Klinicheskayapraktika, 11 (2), 60–80. (in Russian)
8. Belyakov N.A., Boeva E.V., Simakina O.E., SvetlichnayaYu.S., Ogurtsova S.V., Serebryakova S.L., Esaulenko E.V., Zagdyn Z.M., Yazenok A.V., Lioznov D.A. and Stoma I.O. (2022). COVID-19 pandemic and its impact on other infections in Northwest Russia. HIV Infection and Immunosuppressive Disorders, 14(1), 7–24, (in Russian), DOI: 10.22328/2077-9828-2022-14-1-7-24.
9. Bianchetti A., Rozzini R., Guerini F., Boffelli S., Ranieri P., Minelli G., Bianchetti L. and Trabucchi M. (2020). Clinical presentation of COVID-19 in dementia patients. J Nutr Health Aging, 24(6), 560–562, DOI: 10.1007/s12603-020-1389-1.
10. Boyko O.M., Medvedeva T.I., Enikolopov S.N., Vorontsova O.Yu. and Kazmina O.Yu. (2020). Psychological state of people during the COVID-19 pandemic and targets of psychological work. Psikhologicheskieissledovanija, 13(70), 1–12, (in Russian), DOI: 10.54359/ps.v13i70.196.
11. Brest P., Mograbi B., Hofman P. and Milano G. (2021). More light on cancer and COVID-19 reciprocal interaction. British Journal of Cancer, 124, 1344–1345, DOI: 10.1038/s41416-020-01246-0.
12. Briko N.I., Kagramanjan I.N., Nikiforov V.V. Suranova T.G., Chernyavskaya O.P. and Polezhaeva N.A. (2020). Pandemic COVID-19. Prevention Measures in the Russian Federation. Epidemiologija i Vakcinoprofilaktika, 19(2), 4–12, (in Russian), DOI: 10.31631/2073-3046-2020-19-2-4-12.
13. Brown S. and Schuman D.L. (2021). Suicide in the time of COVID-19: A perfect storm. Journal of Rural Health, 37(1), 211–214, DOI: 10.1111/jrh.12458.
14. Burn E., Duarte-Salles T., Fernandez-Bertolin S., et al. (2022). Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. The Lancet Infectious Diseases, 22(8), 1142–1152, DOI: 10.1016/S1473-3099(22)00223-7.
15. Cai S., Shi W., Xu T., Zhang S., Sun J., Liu Y., Zhang Y. and Li K. (2022). Mental health and sleep quality in patients recovered from COVID-19. Chinese Mental Health Journal, Vol 36, No. 6.
16. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, DOI: 10.1016/S0140-6736(20)30211-7.
17. Chernyshev V.M., Voevoda M.I., Strelchenko O.V., Shalygina L.S. and Mingazov I.F. (2021). On the state of health of the population and healthcare in the Siberian Federal Okrug during the pandemic (some results of 2020). Sibirskijj nauchnyjj medicinskijj zhurnal, 41(6), 101–109, (in Russian), DOI: 10.18699/SSMJ20210612.
18. Coronavirus (COVID-19) Outbreaks, Environment and Human Behaviour. Editor Rais Akhtar. Springer Nature (2021). 480 p. DOI: 10.1007/978-3-030-68120-3.
19. Danilova I.A. (2020). Morbidity and Mortality from COVID-19. The Problem of Data Comparability. Demograficheskoeobozrenie, 7(1), 6–26. (in Russian)
20. Desai R., Gandhi Z., Singh S., et al. (2020). Prevalence of Pulmonary Embolism in COVID-19: a Pooled Analysis. SN Comprehensive Clinical Medicine, 2(12), 2722–2725, DOI: 10.1007/s42399-020-00605-5.
21. Docherty A.B., Harrison E.M., Green C.A., et al. (2020). Features of 20133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ, 369, m1985, DOI: 10.1136/bmj.m1985.
22. Driggin E., Madhavan M.V., Bikdeli B., Chuich T., Laracy J., Biondi-Zoccai G., Brown T.S., Der Nigoghossian C., Zidar D.A., Haythe J., Brodie D., Beckman J.A., Kirtane A.J., Stone G.W., Krumholz H.M. and Parikh S.A. (2020). Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am CollCardiol, 75(18), 2352–2371, DOI: 10.1016/j.jacc.2020.03.031.
23. Druzhinin P.V. and Molchanova E.V. (2021). Mortality of the Population of Russian Regions in the Context of the COVID-19 Pandemic. Regionologija, 29(3), 666–685, (in Russian), DOI: 10.15507/2413-1407.116.029.202103.666-685.
24. Ekusheva E.V., Kovalchuk V.V. and Shchukin I.A. Neurological Complications of COVID-19 and Post-Covid Syndrome. 2022. 104 pp. (in Russian)
25. Fei Z., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062, DOI: 10.1016/S0140-6736(20)30566-3.
26. Ferrando S. J., Klepacz L., Lynch S., et al. (2020). COVID-19 psychosis: A potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics, 61, 551–555, DOI: 10.1016/j.psym.2020.05.012.
27. Filev R., Lyubomirova M., Bogov Boris., Kalinov K., Hristova J., Svinarov D., Garev A. and Rostaing L. (2024). Post-Acute Sequelae of SARSCoV-2 Infection (PASC) for Patients-3-Year Follow-Up of Patients with Chronic Kidney Disease. Biomedicines, 12, 1259.
28. Geography, Environment, Sustainability. Special Issue «Geography of the COVID-19 pandemic: public health, economic and environmental consequences». 2021. Vol 14, No 4.
29. Getis, A. and Ord, J.K. (1992), The Analysis of Spatial Association by Use of Distance Statistics. Geographical Analysis, 24: 189-206. https:// doi.org/10.1111/j.1538-4632.1992.tb00261.x
30. Ginzburg A.S., Semenov V.A., Semutnikova E.G., Aleshina M.A., Zakharova P.V. and Lezina E.A. (2020). The Impact of COVID-19 Restrictions on Air Quality in Moscow. Reports of the Russian Academy of Sciences. Nauki o Zemle, №1, 74–79. (in Russian)
31. Goldshteyn E.M. (2020). Factors Affecting Mortality from a New Coronavirus Infection in Different Subjects of the Russian Federation. Zhurnal mikrobiologii, ehpidemiologii i immunobiologii, 97(6), 604-607, (in Russian), DOI: 10.36233/0372-9311-2020-97-6-11.
32. Goroshko N.V., Patsala S.V. and Emelyanova E.K. (2022). Barriers to the fight against the COVID-19 pandemic in the healthcare system of Russia and its regions. Ekonomika. Informatika, 49(2), 217–233, (in Russian), DOI: 10.52575/2687-0932-2022-49-2-217-233.
33. Gushhina O.I. and Lozhkina N.G. (2021). Cardiovascular diseases combined with SARS-CoV-2 viral infection: course and prognosis. Ateroskleroz, 17(3), 97–105, (in Russian), DOI: 10.52727/2078-256X-2021-3-97-1055.
34. Harris A.L. (2020). COVID-19 and cancer research. British Journal of Cancer, 123, 689–690, DOI: 10.1038/s41416-020-0960-1.
35. Hessami A., Shamshirian A., Heydari K., Pourali F., Alizadeh-Navaei R., Moosazadeh M., Abrotan S., Shojaie L., Sedighi S., Shamshirian D. and Rezaei, N. (2021). Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. American Journal of Emergency Medicine, 46, 382–391, DOI: 10.1016/j.ajem.2020.10.022.
36. Hua Q., Liu H.g, Xu X., Zheng D., Wang Q., Liu Y., Zhoy X., Yang R., Ding B., Guo J. and Zhang Z. (2023). Prevalence and associated factors of very early cognitive impairment in COVID-19 convalescents: a study using data from a questionnaire survey. Chinese General Practice, 26 (10), 1234-1240.
37. Huseynov A., Akin I., Duerschmied D. and Scharf R.E. (2023). Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment. Viruses, 15(2), 389, DOI: 10.3390/v15020389.
38. Kaprin A.D., Gameeva E.V., Polyakov A.A., Korniyetskaya A.L., Rubtsova N.A. and Fedenko A.A. (2020). The Impact of the COVID-19 Pandemic on Oncology Practice. Sibirskijj onkologicheskijj zhurnal, 19(3), 5–22, (in Russian), DOI: 10.21294/1814-4861-2020-19-3-5-22.
39. Kemerley A., Gupta A., Thirunavukkarasu M., Maloney M., Burgwardt S. and Maulik N. (2024). COVID-19 Associated Cardiovascular Disease – Risks, Prevention and Management: Heart at Risk Due to COVID-19. Current Issues in Molecular Biology, 46(3), 1904–1920, DOI: 10.3390/cimb46030124.
40. Khalifa S., et al. (2021). Beyond the Pandemic: COVID-19 Pandemic Changed the Face of Life. International Journal of Environmental Research and Public Health, 18(11), 5645, DOI: 10.3390/ijerph18115645.
41. Kotov E.A., Goncharov R.V., Kulchitsky Y.V., Molodsova V.A. and Nikitin B.V. (2022). Spatial Modelling of Key Regional Level Factors of Covid-19 Mortality in Russia. Geography, Environment, Sustainability, 2(15), 71–83, DOI: 10.24057/2071-9388-2021-076.
42. Kravtsiva A.V., Gulyaeva A.A., Golovanova E.D. and Airapetov K.V. (2021). Cardiovascular damage in COVID-19. Vestnik Smolenskojj gosudarstvennojj medicinskojj akademii, 20 (4), 59–65. (in Russian)
43. Krivenko N.V. (2021). Trends in Economic Development and Aspects of Healthcare Reform in Russia in the Context of the COVID-2019 Pandemic. Uroven’ zhizni naselenija regionov Rossii, 17(4), 503–513, (in Russian), DOI: 10.19181/lsprr.2021.17.4.7.
44. Kvasha E.A. and Kharkova T.L. (2022). The COVID-19 Pandemic and Mortality from the Main Causes of Death in the Regions of the Russian Federation in 2020. Regional’nyeissledovanija, 4(78), 61–75, (in Russian), DOI: 10.5922/1994-5280-2022-4-6.
45. Lee J., Kothari A., Bhatt G., Gupta N., Ali A.E., Najam N., Mazroua M., Mansoor T., Amal T., Elsaban M., Deo R., Bansal V. and Kashyap, R. (2023). Cardiac Complications Among Long Covid Patients: A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology, 81(8 suppl), 2115, DOI: 10.1016/S0735-1097(23)02559-7.
46. Libby P. and Luscher T. (2020). COVID-19 is, in the end, an endothelial disease. European Heart Journal, 41(32), 3038–3044, DOI: 10.1093/eurheartj/ehaa623.
47. Liu X., Cheng H. and Jiang F. (2024). Diagnosis and treatment of a case of myocarditis associated with suspected neocoronary infection. Medical Theory and Practice, vol 37, no. 20.
48. Livshits M.L. and Neklyudova N.P. (2020). COVID-19 mortality rate in Russian regions: forecasts and reality. R-Economy, 6(3), 171–182, DOI: 10.15826/recon.2020.6.3.015.
49. Lu H., Stratton C.W. and Tang Y.W. (2020). Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. Journal of Medical Virology, DOI: 10.1002/jmv.25678.
50. Malkhazova S.M., Korennoy F.I., Shartova N.V. and Vatlina T.V. (2021). Covid-19 in the Russian Federation: Regional differences and public health response. Coronavirus (COVID-19) Outbreaks, Environment and Human Behaviour.Cham, Switzerland. Springer International Publishing AG, 283–307.
51. Manchia M., Gathier A.W., Yapici-Eser H., Schmidt M.V., de Quervain D., van Amelsvoort T., Bisson J.I., Cryan J.F., Howes O.D., Pinto L., van der Wee N.J., Domschke K., Branchi I. and Vinkers C.H. (2022). The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves. European Neuropsychopharmacology, 55, 22–83, DOI: 10.1016/j.euroneuro.2021.10.864.
52. McBane R.D. (2021). Arterial thrombosis and coronavirus disease 2019. Mayo Clinic Proceedings, 96(2), 274–276, DOI: 10.1016/j.mayocp.2020.12.009.
53. Medico-geographical Аtlas of Russia «Risk Factors for Oncological Diseases» / ed. S.M. Malkhazova. Faculty of Geography, Lomonosov Moscow State University, 2024. 254 p.
54. Mendes A., Herrmann F.R., Perivier S., et al. (2021). Delirium in older patients with COVID-19: prevalence, risk factors and clinical relevance. The Journals of Gerontology: Series A, 76(8), 142-146, DOI: 10.1093/gerona/glab039.
55. Minakir P.A. (2020). Pandemic Economy: The Russian Path. Prostranstvennajaehkonomika, 16(2), 7–18, (in Russian), DOI: 10.14530/se.2020.2.007-018.
56. Moujaess E., Kourie H.R. and Ghosn M. (2020). Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence. Critical Reviews in Oncology/Hematology, 150, 102972, DOI: 10.1016/j.critrevonc.2020.102972.
57. Nguyen H.C., Nguyen M.H., Do B.N., Tran C.Q., Nguyen T.T., Khue P.M., Van L.P., Tran K.V., Duong T.T., Tran T.V., et al. (2020). People with suspected COVID-19 symptoms were more likely depressed and had lower health-related quality of Life: The potential benefit of health literacy. Journal of Clinical Medicine, 9, 965, DOI: 10.3390/jcm9040965.
58. Nikiforov V.V., Suranova T.G. and ChernobrovkinaT.Ya. (2020). Novel coronavirus infection (COVID-19): clinical and epidemiological aspects. Arkhiv vnutrennejj mediciny, 10(2), 87–93, (in Russian), DOI: 10.20514/2226-6704-2020-10-2-87-93.
59. Nikitina A.Yu., Chimagomedova A.Sh. and Levin O.S. (2021). Neurological manifestations of COVID-19 in the elderly. Zhurnalnevrologiiipsikhiatrii, 121:10:2, 5–15, (in Russian), DOI: 10.17116/jnevro20211211025.
60. Nygaard U., Holm M., Rabie H. et al. (2024). The pattern of childhood infections during and after the COVID-19 pandemic. The Lancet Child & Adolescent Health, Volume 8, Issue 12, 910-920, DOI: 10.1016/S2352-4642(24)00236-0.
61. Ong I., Kolson D. and Schindler M. (2023). Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC). Biomedicines, 11, 377.
62. O’Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., Wilkinson T.J., Hawthorne G., Curtis F., Kingsnorth A.P., Almaqhawi A., Ward T., Ayoubkhani D., Banerjee A., Calvert M., Shafran R., Stephenson T., Sterne J., Ward H., Evans R.A., Zaccardi F., Wright S. and Khunti K. (2022). The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. eClinicalMedicine, 55, 101762, DOI: 10.1016/j.eclinm.2022.101762.
63. Parfenov V.A. and Kulesh A.A. (2022). Acute and late neurological disorders in patients who have had coronavirus infection. Nevrologija, nejjropsikhiatrija, psikhosomatika, 14(3), 4–11. (in Russian)
64. Peng M. (2020). Outbreak of COVID-19: An emerging global pandemic threat. Biomedicine & Pharmacotherapy, 129, 110499, DOI: 10.1016/j.biopha.2020.
65. Perkhov V.I. and Gridnev O.V. (2020). Lessons of the COVID-19 pandemic for public health policy. Sovremennye problem zdravookhran enijaimedicinskojjstatistiki, 2, 206–222, (in Russian), DOI: 10.24411/2312-2935-2020-10043.
66. Pesennikova E.V. and Perkhov V.I. (2020). Directions for the Development of Medicine and Healthcare in the Post-Pandemic World. Sovremennye problem zdravookhranenijaimedicinskojjstatistiki, 4, 535–551, (in Russian), DOI: 10.24411/2312-2935-2020-00130.
67. Petrilli C.M., Jones S.A., Yang J., Rajagopalan H., O’Donnell L., Chernyak Y., Tobin K.A., Cerfolio R.J., Francois F. and Horwitz L.I. (2020). Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ, 369, m1966, DOI: 10.1136/bmj.m1966.
68. Pogosova N.V., Kuchiev D.T. and Popova A.B. (2023). Consequences of COVID-19 at a Remote Stage after Hospitalization According to Clinical, Instrumental and Laboratory Research Methods. Kardiologicheskijjvestnik, 18(4), 56–66, (in Russian), DOI: 10.17116/Cardiobulletin20231804156.
69. Poloni T.E., Carlos A.F., Cairati, M., et al. (2020). Prevalence and prognostic value of Delirium as the initial presentation of COVID-19 in the elderly with dementia: an Italian retrospective study. Clinical Medicine, 26, 100490, DOI: 10.1016/j.eclinm.2020.100490.
70. Poyiadji N., Shahin G., Noujaim D., et al. (2020). COVID19 associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology, 296(2), 119–120, DOI: 10.1148/radiol.2020201187.
71. Qin S., Yanan Z., Yanhua L., Ling H., Ting Y., Jiahui S., Likui W., Xin Z., Xiaopeng M. and George F.G. (2024). Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants. The Lancet Regional Health – Western Pacific, Volume 52, 101218.
72. Ranasinghe L., Achar J., Gröschel M.I. et al. (2022). Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data. Lancet Glob Health, Dec 10(12), e1774-e1781, DOI: 10.1016/S2214-109X(22)00414-4.
73. Richardson, S., Hirsch, J. S., Narasimhan, M., et al. (2020). Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA, 323(20), 2052–2059, DOI: 10.1001/jama.2020.6775.
74. Rodríguez-Rey R., Garrido-Hernansaiz H. and Collado S. (2020). Psychological impact and associated factors during the initial stage of the coronavirus (COVID-19) pandemic among the general population in Spain. Frontiers in Psychology, 11, 1540, DOI: 10.3389/fpsyg.2020.01540.
75. Rogers J., Chesney E., Oliver D., et al. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry, 7(7), 611–627, DOI: 10.1016/S2215-0366(20)30203-0.
76. Romanov Yu.A. (2022). SARS-CoV-2, COVID-19 and cardiovascular complications: a view from the perspective of vascular endothelium. Kardiologicheskijj vestnik, 17(1), 21–28, (in Russian), DOI: 10.17116/Cardiobulletin20221701121.
77. Rozanov V.A. (2020). Urgent Tasks in the Sphere of Suicide Prevention in Connection with the COVID-19 Pandemic. Suicidologija, 11(1), 39–52, (in Russian), DOI: 10.32878/suiciderus.20-11-01(38)-39-52.
78. Rozanov V.A. and Semenova N.V. (2022). Suicidal behavior in the context of the COVID-19 pandemic. Psikhiatrija, 20(3), 74–84, (in Russian), DOI: 10.30629/2618-6667-2022-20-3-74-84.
79. Rugol L.V. (2023). Assessing hospital emergency preparedness. Social’nye aspekty zdorov’a naselenia; 69(5):6, (in Russian), DOI: 10.21045/2071-5021-2023-69-5-6.
80. Shelgunov V.A., Zubko A.V., Kungurcev O.V. and Zaporozhchenko V.G. (2023). The impact of a new coronavirus infection on the development of chronicnon-communicable diseases. Social’nyeaspektyzdorov’janaselenija, 69(3), 5, (in Russian), DOI: 10.21045/2071-5021-2023-69-3-5.
81. Sher L. (2020). The impact of the COVID-19 pandemic on suicide rates. QJM: An International Journal of Medicine, 113(10), 707–712, DOI: 10.1093/qjmed/hcaa202.
82. Simonenko V.V., Vakal T.N., Mikhalik D.S., Zhukov G.V. and Nikolaenkova L.I. (2021). Neurological complications after coronavirus infection. Vestnik Smolenskojj gosudarstvennojj medicinskojj akademii, 20 (2), 59–64. (in Russian)
83. Starodubov V.I., Kadyrov F.N., Obukhova O.V., Bazarova I.N., EndovitskayaYu.V. and NesvetailoN.Ya. (2020). The impact of coronavirus COVID-19 on the situation in Russian healthcare. Menedzher zdravookhranenija, 4, 58–71. (in Russian)
84. Sugraliev A.B. (2021). Heart damage in patients with COVID-19. Kardiologija, 61(4), 15–23, (in Russian), DOI: 10.18087/cardio.2021.4.n1408.
85. Timonin S.A., Klimkin I., Shkolnikov V.M., Andreev E.M., Mckee M. and Leon D.A. (2021). Excess mortality in Russia and its regions compared to high income countries: An analysis of monthly series of 2020. Population Health, 17. Tsvetkova L.A., Kurakov F.A. and Кarmina R.L. (2024). Key trends in the development of global public health: 2021–2023. Public Health, 4(2):4–17, (in Russian), DOI 10.32687/0869-866X-2024-32-2-127-133.
86. Ueda M., Nordström R. and Matsubayashi T. (2021). Suicide and mental health during the COVID-19 pandemic in Japan. Journal of Public Health (Oxf ), DOI: 10.1093/pubmed/fdab113.
87. Ulumbekova G.E. (2020). Proposals for the reform of healthcare in the Russian Federation after the peak of the COVID-19 pandemic. Vestnik VSHOUZ, 6(2), 9–26, (in Russian), DOI: 10.24411/2411-8621-2020-12001.
88. Ulumbekova G.E. and Ginoyan A.B. (2022). Lessons of the COVID-19 pandemic for healthcare in Russia. Nauchnye Trudy Vol’nogo ekonomicheskogo obshhestva Rossii, 234(2), 54–86, (in Russian), DOI: 10.38197/2072-2060-2022-234-2-54-86.
89. Varga Z., Flammer A.J., Steiger P., et al. (2020). Endothelial cell infection and endotheliitis in COVID-19. The Lancet, 395, 1417–1418, DOI: 10.1016/S0140-6736(20)30937-5.
90. Vorobyeva O.V. and Romanova L.P. (2022). Clinical case of SARS-CoV-2 infection with the development of acute myocardial infarction, myomalacia and hemopericardium. Profilakticheskaja medicina, 25(6), 75–79, (in Russian), DOI: 10.17116/profmed20222506175.
91. Wang D., Hu B., Hu C., Zhu F., Liu X. and Zhang J. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China. JAMA, DOI: 10.1001/jama.2020.1585.
92. Xie Y., Xu E., Bowe B., et al. (2022). Long-term cardiovascular outcomes of COVID-19. Nature Medicine, 28(3), 583–590, DOI: 10.1038s41591-022-01689-3.
93. Xu J., Xiao W., Liang X., et al. (2021). A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity. BMC Public Health, 21(1), 1533, DOI: 10.1186/s12889-021-11051-w.
94. Yakovleva O.B., Safarova T.P. and Tsvetaeva D.A. (2023). The Impact of the COVID-19 Pandemic on the Occurrence and Course of Mental Illnesses in the Elderly. Zhurnal nevrologii i psikhiatrii, 123(5), 131–138, (in Russian), DOI: 10.17116/jnevro2023123051131.
95. Yong S. and Liu S. (2021). Proposed subtypes of post-COVID-19 syndrome (or long COVID) and their respective potential therapies. Reviews in Medical Virology, DOI: 10.1002/rmv.2315.
96. Yusov A.A. and Alpidovskaya O.V. (2023). Left ventricular thrombosis and a cute cardiovascular failure in patients after SARS-CoV-2 infection. Profilakticheskaja medicina, 26(11), 78–81, (in Russian), DOI: 10.17116/profmed20232611178.
97. Zhang L. and Zhang M. (2024). Changes in coagulation indices and obstetric complications in third trimester pregnant women with COVID-19. Chin J School Doctor, Vol.38, No.6, 455–458.
98. Zhang Y. and Ma Z.F. (2020). Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: A cross-sectional study. International Journal of Environmental Research and Public Health, 17, 2381, DOI: 10.3390/ijerph17072381.
99. Zhao Y., Shi L., Jiang Z., Zeng N., Mei H., Lu Y., Yang J., Jin F., Ni S., Wu S., Su S., Zheng Y., Yuan K., Yan W., Sun S., Meng S., Sun J., Khan Z., Aarsland D., Shi J., Li X., Bao Y. and Lu L. (2023). The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol Psychiatry. Apr; 28(4):1793-1801. DOI: 10.1038/s41380-023-01951-1.
Review
For citations:
Malkhazova S.M., Korennoy F.I., Vatlina T.V., Wang L., Orlov D.S. The COVID-19 Pandemic and its Consequences for Public Health: Medico-Geographical Aspect. GEOGRAPHY, ENVIRONMENT, SUSTAINABILITY. 2025;18(2):175-188. https://doi.org/10.24057/2071-9388-2025-3857
Views:
18
Email this article 